Philippines proposes compulsory adoption of ASEAN CTD
This article was originally published in SRA
The Philippine pharmaceutical industry association has reacted positively to proposals by the Philippines Bureau of Food And Drugs to streamline the registration process for pharmaceutical products and improve patient access to new medicines1,2. When finalised, the proposals are expected to, among other things, amend the existing drug registration guidelines and make compulsory the implementation of the Association of South East Asian Nations’ common technical dossier and common technical requirements as the basic parameters for registering pharmaceutical products.
You may also be interested in...
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.